R. Sanchez

BIRC5 is a target for molecular imaging and detection of human pancreatic cancer.

J. Willey, J. Nemunaitis, F. Brunicardi, 2019, Cancer letters.

A novel synthetic human insulin super promoter for targeting PDX-1-expressing pancreatic cancer.

J. Willey, J. Nemunaitis, F. Brunicardi, 2018, Cancer letters.

Cancer microarray data weighted gene co-expression network analysis identifies a gene module and hub genes shared across nine types of solid cancer

F. Brunicardi, D. Heidt, J.-H. Yu, 2017 .

PDX1 associated therapy in translational medicine.

J. Nemunaitis, F. Brunicardi, E. Rozengurt, 2016, Annals of translational medicine.

Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.

J. Nemunaitis, C. Ricordi, E. Rozengurt, 2016, Current molecular medicine.

Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin

J. Nemunaitis, F. Brunicardi, E. Rozengurt, 2014, Front. Physiol..

Pancreatic cancer actionable genes in precision medicine and personalized surgery.

J. Nemunaitis, F. Brunicardi, E. Rozengurt, 2017, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes.

R. Gibbs, D. Edwards, M. Gingras, 2011, Surgery.

Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinoma.

R. Damoiseaux, J. Nemunaitis, Jian-Ting Zhang, 2020, Cancer letters.

Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform

D. Rao, N. Senzer, J. Nemunaitis, 2014, Cancer Gene Therapy.

PDX-1 Is a Therapeutic Target for Pancreatic Cancer, Insulinoma and Islet Neoplasia Using a Novel RNA Interference Platform

R. Gibbs, D. Rao, N. Senzer, 2012, PloS one.